Predicting final visual acuity following cataract surgery

预测白内障手术后的最终视力

基本信息

  • 批准号:
    9215348
  • 负责人:
  • 金额:
    $ 36.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-01 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

ABSTRACT: Cataract surgery is the most commonly performed surgery in the United States. Despite this, we know surprisingly little about visual outcomes and rates of complications following contemporary cataract surgery, especially in population subgroups. This lack of knowledge is troubling given that emerging research from Europe suggests that cataract surgery might be ineffective for up to 6% of patients and present significant harms to another 2- 5%. Cystoid macular edema (CME), for example, is a common postoperative complication of cataract surgery. Since the adoption of optical coherence tomography, CME incidence has risen from ~2% to ~40%. However, cataract surgeons lack a clear understanding of what this diagnosis means. To address this issue, we propose a cohort study to generate real-world knowledge about cataract surgery prognosis, including visual outcomes and complication rates; CME diagnostic criteria that correlate with late postoperative vision loss; the prevention of significant CME; and differences in these topics among vulnerable population subgroups. The proposed study will include comprehensive, prospectively recorded data for approximately 186,000 patients and more than 250,000 eyes that received surgery at Kaiser Permanente Northern California from 2007 to 2016. The study will be the largest in the U.S.; will use detailed, comprehensive information that is prospectively recorded into the electronic medical record; and will use modern analytic techniques to ensure valid analyses. The well- characterized, community-based population is diverse, with 29% of patients being non-white and 43% having an ocular comorbidity. Together with the large number of cases, this high level of diversity will enable detailed sensitivity and subgroup analysis. Our results will allow cataract surgeons to individualize care for their patients. The results will also provide desperately needed evidence-based diagnostic criteria for CME. These criteria can be used in research studies, in clinical practice, and to develop practice guidelines. The exceptional volume of cataract surgery justifies research to improve decision-making of this life-changing surgery.
摘要:白内障手术是美国最常见的手术 States.尽管如此,我们对视力结果和患病率的了解却少得令人惊讶。 现代白内障手术后的并发症,特别是在人群亚组中。这 缺乏知识是令人不安的,因为来自欧洲的新研究表明,白内障 手术可能对高达6%的患者无效,并对另外2%的患者造成重大伤害 百分之五囊样黄斑水肿(CME),例如,是一种常见的术后并发症, 白内障手术自光学相干层析成像技术被采用以来,CME的发生率有所上升 从约2%到约40%。然而,白内障外科医生缺乏一个清晰的认识, 诊断手段。为了解决这个问题,我们提出了一个队列研究,以产生现实世界的 了解白内障手术预后,包括视力结果和并发症发生率; 与术后晚期视力丧失相关的CME诊断标准; 显著的继续医学教育;以及弱势群体在这些问题上的差异。的 拟议的研究将包括全面的,前瞻性记录的数据, 186,000名患者和超过250,000只眼睛在Kaiser Permanente接受手术 2007年至2016年的北方加州。这项研究将是美国规模最大的研究。将使用 详细、全面的信息,这些信息将被前瞻性地记录到电子医疗记录中。 记录;并将使用现代分析技术,以确保有效的分析。井- 以社区为基础的特征人群是多样化的,29%的患者是非白人 43%有眼部合并症。加上案件数量多, 多样性将使详细的敏感性和亚组分析。我们的研究结果将使白内障 外科医生为病人提供个性化护理。其结果也将提供绝望 需要循证医学诊断标准。这些标准可用于研究 研究,在临床实践中,并制定实践指南。的特殊体积 白内障手术证明了研究的合理性,以改善这种改变生活的手术的决策。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LISA J HERRINTON其他文献

LISA J HERRINTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LISA J HERRINTON', 18)}}的其他基金

Comparative Effectiveness of Prophylaxis in Cataract Surgery
白内障手术预防的比较效果
  • 批准号:
    8428618
  • 财政年份:
    2013
  • 资助金额:
    $ 36.96万
  • 项目类别:
Psoriasis treatments, cardiovascular disease, and diabetes
牛皮癣治疗、心血管疾病和糖尿病
  • 批准号:
    8506094
  • 财政年份:
    2013
  • 资助金额:
    $ 36.96万
  • 项目类别:
Comparative Effectiveness of Prophylaxis in Cataract Surgery
白内障手术预防的比较效果
  • 批准号:
    8600280
  • 财政年份:
    2013
  • 资助金额:
    $ 36.96万
  • 项目类别:
Psoriasis treatments, cardiovascular disease, and diabetes
牛皮癣治疗、心血管疾病和糖尿病
  • 批准号:
    8728163
  • 财政年份:
    2013
  • 资助金额:
    $ 36.96万
  • 项目类别:
Kaiser Permanente Autoimmune Disease Registry
凯撒永久自身免疫性疾病登记处
  • 批准号:
    7815188
  • 财政年份:
    2009
  • 资助金额:
    $ 36.96万
  • 项目类别:
Kaiser Permanente Autoimmune Disease Registry
凯撒永久自身免疫性疾病登记处
  • 批准号:
    7937015
  • 财政年份:
    2009
  • 资助金额:
    $ 36.96万
  • 项目类别:
HR-QOL in Colorectal Cancer Survivors with Stomas
有造口的结直肠癌幸存者的 HR-QOL
  • 批准号:
    8296695
  • 财政年份:
    2004
  • 资助金额:
    $ 36.96万
  • 项目类别:
HR-QOL in Colorectal Cancer Survivors with Stomas
有造口的结直肠癌幸存者的 HR-QOL
  • 批准号:
    7653542
  • 财政年份:
    2004
  • 资助金额:
    $ 36.96万
  • 项目类别:
HR-QOL in Colorectal Cancer Survivors with Stomas
有造口的结直肠癌幸存者的 HR-QOL
  • 批准号:
    8465832
  • 财政年份:
    2004
  • 资助金额:
    $ 36.96万
  • 项目类别:
HR-QOL in Colorectal Cancer Survivors with Stomas
有造口的结直肠癌幸存者的 HR-QOL
  • 批准号:
    8069867
  • 财政年份:
    2004
  • 资助金额:
    $ 36.96万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.96万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.96万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 36.96万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 36.96万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了